+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antimicrobial Resistance Diagnostic Market - Global Forecast 2026-2032- Product Image
Antimicrobial Resistance Diagnostic Market - Global Forecast 2026-2032- Product Image
Sale

Antimicrobial Resistance Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6014956
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antimicrobial Resistance Diagnostic Market is projected to reach USD 5.40 Billion in 2026. It is expected to continue growing at a CAGR of 6.69%, reaching USD 7.98 Billion by 2032.

Antimicrobial Resistance Diagnostics: Executive Overview

Antimicrobial resistance (AMR) diagnostics identify pathogens and determine antimicrobial susceptibility, supporting more targeted treatment and infection-control decisions. Their importance is rising as resistant infections complicate routine care, increase pressure on health systems, and reduce the reliability of empirical therapy. The field includes culture-based susceptibility testing, molecular assays, rapid phenotypic methods, syndromic panels, and sequencing-enabled approaches. Adoption depends on clinical utility, turnaround time, laboratory capacity, reimbursement, regulatory requirements, and integration with antimicrobial stewardship programs.

Diagnostics Are Moving From Delayed Confirmation to Actionable Results

The diagnostic landscape is shifting toward faster and more clinically actionable testing. Conventional culture remains important because it can provide isolate-level susceptibility information, but its turnaround time can delay treatment optimization. Molecular methods can identify resistance markers rapidly, although detected genes do not always predict the full phenotype and may not capture emerging mechanisms. Consequently, laboratories and care providers increasingly require complementary workflows that combine rapid detection with confirmatory susceptibility testing.

Implementation is also becoming more system-oriented. Hospitals are linking diagnostic results with antimicrobial stewardship, infection prevention, electronic health records, and public-health surveillance. Data standardization, quality assurance, workforce training, specimen quality, and laboratory-network connectivity are therefore as important as assay performance. The strongest operational value comes when a result changes prescribing, isolation, escalation, or de-escalation decisions.

Artificial Intelligence Strengthens Interpretation, Surveillance, and Workflow Design

Artificial intelligence can support AMR diagnostics by interpreting complex susceptibility patterns, prioritizing abnormal results, identifying probable resistance phenotypes, and helping laboratories manage workload. Machine-learning models may also combine laboratory, clinical, prescribing, and epidemiological data to improve risk stratification and guide selection of tests. Natural-language processing can extract resistance-related information from clinical records and microbiology reports, while anomaly detection can help identify unusual clusters that warrant investigation.

The benefits depend on representative training data, external validation, transparent performance reporting, and careful monitoring for bias. AI should support rather than replace microbiologist and clinician judgment, particularly when results are discordant or resistance mechanisms are novel. Secure data governance, interoperability, explainability, and clear accountability are essential before algorithmic outputs are incorporated into treatment or infection-control pathways.

Regional Priorities Differ With Burden, Laboratory Capacity, and Surveillance Maturity

North America generally emphasizes rapid hospital diagnostics, stewardship integration, laboratory automation, and coordinated surveillance. Europe combines national and cross-border surveillance with strong attention to quality standards, prudent antimicrobial use, and equitable access. Asia-Pacific contains highly diverse laboratory environments, creating demand for both advanced molecular testing and robust, affordable culture-based infrastructure. Latin America is focused on expanding timely microbiology, strengthening referral networks, and improving access beyond major urban centers.

The Middle East is investing in hospital laboratory modernization, infection prevention, and preparedness for healthcare-associated outbreaks, while workforce and interoperability gaps remain relevant. Africa’s priorities include dependable specimen transport, decentralized testing where appropriate, external quality assurance, and linkage between clinical laboratories and public-health programs. Across all regions, diagnostic strategies are most effective when adapted to local resistance patterns, available treatment options, laboratory staffing, and supply-chain reliability.

International Groups Align Around Surveillance, Stewardship, and Diagnostic Access

ASEAN countries face substantial variation in laboratory capacity, pathogen prevalence, and health-system resources, making regional standards, shared surveillance, and referral collaboration particularly valuable. BRICS members encompass large and diverse populations and can advance AMR response through domestic manufacturing capability, data exchange, research collaboration, and stronger laboratory networks. The European Union benefits from coordinated surveillance and regulatory cooperation, while continued harmonization of data and access remains important.

G7 members generally have mature diagnostic infrastructures and can contribute through research funding, technology validation, workforce support, and international capacity building. GCC countries are prioritizing high-quality hospital diagnostics, infection prevention, and health-system preparedness, with opportunities to strengthen regional data interoperability. NATO members have a shared interest in resilient medical logistics, outbreak readiness, and diagnostics that remain dependable during crises, humanitarian operations, and disrupted supply chains.

Country-Level Strategies Reflect Distinct Health-System and Laboratory Conditions

Australia combines national stewardship and surveillance priorities with a need to serve geographically dispersed communities. Brazil is strengthening laboratory networks and public-health coordination across a large and diverse territory. Canada emphasizes coordinated surveillance, stewardship, and access across provincial and remote settings. China is expanding diagnostic capacity while addressing regional variation and integrating laboratory data into broader AMR controls.

France, Germany, Italy, and Spain are advancing hospital stewardship, surveillance, and quality-managed laboratory services within a coordinated European context. India faces a particularly broad requirement for affordable, scalable testing across public and private care, supported by stronger referral pathways and workforce development. Japan and South Korea combine advanced laboratory capabilities with aging-population and healthcare-associated infection priorities. Mexico is working to improve access, surveillance, and laboratory coordination across decentralized services.

Russia’s diagnostic priorities include maintaining laboratory capacity, surveillance, and supply continuity across a geographically extensive system. The United Kingdom continues to link diagnostics with stewardship, national surveillance, and preparedness. The United States is focused on rapid testing, laboratory-network coordination, infection prevention, and the translation of resistance data into prescribing decisions. In every country, implementation must reflect local guidelines, procurement systems, reimbursement, and regulatory pathways.

Industry Leaders Should Build Integrated, Evidence-Based Diagnostic Pathways

Leaders should prioritize tests that answer a defined clinical or public-health question and demonstrate how results change management. Evaluation programs should measure analytical performance, turnaround time, clinical utility, antibiotic use, patient outcomes, workflow impact, and total implementation requirements rather than relying on speed alone.

Organizations should pair rapid assays with confirmatory methods, stewardship protocols, and escalation procedures for unexpected results. Investments in laboratory information systems, interoperable reporting, staff training, quality assurance, and reliable specimen logistics can determine whether technical performance translates into patient benefit. Developers and providers should also design for varied settings, including resource-constrained facilities, and engage regulators, clinicians, microbiologists, patients, and public-health authorities early.

Finally, leaders should establish governance for AI and diagnostic data, including validation across populations, cybersecurity, model monitoring, explainability, and human oversight. Partnerships that improve surveillance and responsible data sharing can accelerate learning while protecting confidentiality and maintaining trust.

Research Methodology for the Antimicrobial Resistance Diagnostics Assessment

This assessment uses a structured review of authoritative public-health guidance, peer-reviewed scientific literature, regulatory and laboratory standards, surveillance publications, clinical evidence, and documented health-system practices. Evidence is evaluated for recency, methodological quality, geographic relevance, and applicability to antimicrobial resistance diagnostics.

The analysis distinguishes diagnostic modalities, clinical settings, implementation requirements, stewardship integration, surveillance functions, and enabling technologies such as artificial intelligence. Regional, group, and country perspectives are synthesized from documented differences in resistance burden, laboratory infrastructure, policy priorities, workforce capacity, and healthcare delivery. Claims are framed qualitatively and avoid unsupported estimates. Uncertainty is retained where evidence is heterogeneous, rapidly evolving, or dependent on local context.

Diagnostics Are Foundational to a More Precise AMR Response

Antimicrobial resistance diagnostics are becoming central to safer prescribing, faster infection-control action, and stronger surveillance. No single technology addresses every clinical or epidemiological need: culture and susceptibility testing remain foundational, while molecular, phenotypic, sequencing, and AI-enabled tools can improve speed, scale, and interpretation when appropriately validated.

Progress will depend on connecting technology with skilled laboratories, stewardship teams, interoperable data, quality systems, and equitable access. Leaders that evaluate diagnostics by their real-world effect on decisions and outcomes-not by technical novelty alone-will be better positioned to support resilient, evidence-based responses to AMR across hospitals, communities, and public-health networks.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antimicrobial Resistance Diagnostic Market, by Technology
7.1. Introduction
7.2. Mass Spectrometry
7.3. Microarray
7.4. Next Generation Sequencing
7.4.1. Long Read Sequencing
7.4.2. Short Read Sequencing
7.5. Polymerase Chain Reaction (PCR)
8. Antimicrobial Resistance Diagnostic Market, by Product
8.1. Introduction
8.2. Instruments
8.3. Reagents & Consumables
8.4. Software & Services
8.4.1. Services
8.4.1.1. Consulting Services
8.4.1.2. Support Services
8.4.2. Software
9. Antimicrobial Resistance Diagnostic Market, by Test Type
9.1. Introduction
9.2. Genotypic Tests
9.2.1. Targeted Assays
9.2.2. Whole Genome Sequencing
9.3. Phenotypic Tests
10. Antimicrobial Resistance Diagnostic Market, by Sample Type
10.1. Introduction
10.2. Blood Samples
10.3. Respiratory Samples
10.4. Urine Samples
10.5. Wound Swabs
11. Antimicrobial Resistance Diagnostic Market, by Pathogen
11.1. Introduction
11.2. Fungi
11.3. Gram Negative Bacteria
11.4. Gram Positive Bacteria
12. Antimicrobial Resistance Diagnostic Market, by Application
12.1. Introduction
12.2. Human Diagnostics
12.3. Pharmaceutical & Biopharmaceutical
12.4. Veterinary Diagnostics
13. Antimicrobial Resistance Diagnostic Market, by End User
13.1. Introduction
13.2. Academic & Research Institutions
13.3. Diagnostic Centers
13.4. Hospitals & Clinics
13.5. Reference Laboratories
14. Antimicrobial Resistance Diagnostic Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Antimicrobial Resistance Diagnostic Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Antimicrobial Resistance Diagnostic Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Abbott Laboratories
18.2. Becton, Dickinson and Company
18.3. Bio-Rad Laboratories, Inc.
18.4. bioMérieux SA
18.5. Bruker Corporation
18.6. Danaher Corporation
18.7. QIAGEN N.V.
18.8. Roche Diagnostics
18.9. Siemens Healthineers AG
18.10. Thermo Fisher Scientific Inc.
18.11. Vela Diagnostics
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Antimicrobial Resistance Diagnostic Market, Years Considered for the Study
FIGURE 2. Global Antimicrobial Resistance Diagnostic Market, Research Design
FIGURE 3. Global Antimicrobial Resistance Diagnostic Market, Research Framework
FIGURE 4. Global Antimicrobial Resistance Diagnostic Market, Data Triangulation
FIGURE 5. Global Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Antimicrobial Resistance Diagnostic Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Antimicrobial Resistance Diagnostic Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Antimicrobial Resistance Diagnostic Market Size, by Product, 2025 vs 2032 (%)
FIGURE 9. Global Antimicrobial Resistance Diagnostic Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 11. Global Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2025 vs 2032 (%)
FIGURE 15. Global Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Antimicrobial Resistance Diagnostic Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Antimicrobial Resistance Diagnostic Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Antimicrobial Resistance Diagnostic Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Antimicrobial Resistance Diagnostic Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Antimicrobial Resistance Diagnostic Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Antimicrobial Resistance Diagnostic Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Antimicrobial Resistance Diagnostic Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Antimicrobial Resistance Diagnostic Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Antimicrobial Resistance Diagnostic Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Antimicrobial Resistance Diagnostic Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Antimicrobial Resistance Diagnostic Market Segmentation & Coverage
TABLE 2. Global Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 3. Global Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Long Read Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Long Read Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Long Read Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Short Read Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Short Read Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Short Read Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Polymerase Chain Reaction (PCR) Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Polymerase Chain Reaction (PCR) Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Polymerase Chain Reaction (PCR) Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 23. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Consulting Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Consulting Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Consulting Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Support Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Support Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Support Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 45. Global Genotypic Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Genotypic Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Genotypic Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Targeted Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Targeted Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Targeted Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Phenotypic Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Phenotypic Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Phenotypic Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 58. Global Blood Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Blood Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Blood Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Respiratory Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Respiratory Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Respiratory Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Urine Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Urine Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Urine Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Wound Swabs Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Wound Swabs Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Wound Swabs Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 71. Global Fungi Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Fungi Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Fungi Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Gram Negative Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Gram Negative Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Gram Negative Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Gram Positive Bacteria Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Gram Positive Bacteria Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Gram Positive Bacteria Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Global Human Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Human Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Human Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Pharmaceutical & Biopharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Pharmaceutical & Biopharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Pharmaceutical & Biopharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Veterinary Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Veterinary Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Veterinary Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Global Academic & Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Academic & Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Academic & Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. North America Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. North America Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. North America Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 119. North America Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 120. North America Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 121. North America Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 122. North America Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 123. North America Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 124. North America Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 125. North America Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 126. North America Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. North America Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Latin America Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Latin America Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 130. Latin America Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 131. Latin America Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 132. Latin America Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 133. Latin America Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 134. Latin America Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 135. Latin America Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 136. Latin America Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 137. Latin America Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 138. Latin America Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Latin America Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Europe Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Europe Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 142. Europe Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 143. Europe Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 144. Europe Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 145. Europe Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 146. Europe Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 147. Europe Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 148. Europe Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 149. Europe Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 150. Europe Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 151. Europe Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Middle East Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Middle East Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Middle East Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 155. Middle East Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 156. Middle East Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 157. Middle East Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 158. Middle East Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 159. Middle East Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 160. Middle East Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. Middle East Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 162. Middle East Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Middle East Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Africa Antimicrobial Resistance Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Africa Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Africa Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 167. Africa Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 168. Africa Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 169. Africa Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 170. Africa Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 171. Africa Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 172. Africa Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 173. Africa Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 174. Africa Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Africa Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Global Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 180. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 181. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 182. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 183. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 184. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 185. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 186. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 187. ASEAN Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. ASEAN Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. GCC Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. GCC Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 191. GCC Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 192. GCC Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 193. GCC Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 194. GCC Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 195. GCC Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 196. GCC Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 197. GCC Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. GCC Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 199. GCC Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. GCC Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. European Union Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. European Union Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. European Union Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 204. European Union Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 205. European Union Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 206. European Union Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 207. European Union Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 208. European Union Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 209. European Union Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 210. European Union Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 211. European Union Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. European Union Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. BRICS Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. BRICS Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 215. BRICS Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 216. BRICS Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 217. BRICS Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 218. BRICS Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 219. BRICS Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 220. BRICS Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 221. BRICS Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 222. BRICS Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 223. BRICS Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. BRICS Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. G7 Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. G7 Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. G7 Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 228. G7 Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 229. G7 Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 230. G7 Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 231. G7 Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 232. G7 Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 233. G7 Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 234. G7 Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 235. G7 Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. G7 Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. NATO Antimicrobial Resistance Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. NATO Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 239. NATO Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 240. NATO Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. NATO Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 242. NATO Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 243. NATO Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 244. NATO Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 245. NATO Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 246. NATO Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 247. NATO Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. NATO Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Global Antimicrobial Resistance Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 250. United States Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 251. United States Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 252. United States Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 253. United States Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 254. United States Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 255. United States Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 256. United States Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 257. United States Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 258. United States Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 259. United States Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 260. United States Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. United States Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Canada Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 263. Canada Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. Canada Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 265. Canada Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 266. Canada Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 267. Canada Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 268. Canada Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 269. Canada Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 270. Canada Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 271. Canada Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 272. Canada Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. Canada Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Mexico Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 275. Mexico Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. Mexico Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 277. Mexico Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 278. Mexico Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 279. Mexico Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 280. Mexico Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 281. Mexico Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 282. Mexico Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 283. Mexico Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 284. Mexico Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. Mexico Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Brazil Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 287. Brazil Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Brazil Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 289. Brazil Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 290. Brazil Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 291. Brazil Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 292. Brazil Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 293. Brazil Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 294. Brazil Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 295. Brazil Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 296. Brazil Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. Brazil Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 298. United Kingdom Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 299. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 300. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 301. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 302. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 303. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 304. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 305. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 306. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 307. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 308. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. United Kingdom Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Germany Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 311. Germany Antimicrobial Resistance Diagnostic Market Size, by Technology, 2017-2032 (USD Million)
TABLE 312. Germany Antimicrobial Resistance Diagnostic Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 313. Germany Antimicrobial Resistance Diagnostic Market Size, by Product, 2017-2032 (USD Million)
TABLE 314. Germany Antimicrobial Resistance Diagnostic Market Size, by Software & Services, 2017-2032 (USD Million)
TABLE 315. Germany Antimicrobial Resistance Diagnostic Market Size, by Services, 2017-2032 (USD Million)
TABLE 316. Germany Antimicrobial Resistance Diagnostic Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 317. Germany Antimicrobial Resistance Diagnostic Market Size, by Genotypic Tests, 2017-2032 (USD Million)
TABLE 318. Germany Antimicrobial Resistance Diagnostic Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 319. Germany Antimicrobial Resistance Diagnostic Market Size, by Pathogen, 2017-2032 (USD Million)
TABLE 320. Germany Antimicrobial Resistance Diagnostic Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. Germany Antimicrobial Resistance Diagnostic Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. France Antimicrobial Resistance Diagnostic Market Size, 2017-2032 (USD Million)
TABLE 323. France Antimicrobial

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bruker Corporation
  • Danaher Corporation
  • QIAGEN N.V.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics

Related Topics

Related Reports

Antimicrobials Market - Global Forecast 2026-2032 - Product Image

Antimicrobials Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Antibiotic Resistance Market - Global Forecast 2026-2032 - Product Image

Antibiotic Resistance Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Antimicrobial Resistance Surveillance - Global Strategic Business Report - Product Image

Antimicrobial Resistance Surveillance - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Antimicrobial Resistance Diagnostics - Global Strategic Business Report - Product Image

Antimicrobial Resistance Diagnostics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Report 2026 - Product Image

Antimicrobial Resistance Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.